Gentherm Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.6B+8.5% YoYTTM through 30 Jun 2026
Net Income $26.6M-59.1% YoYTTM through 30 Jun 2026
Free Cash Flow $41.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 24.2% |
| EBITDA Margin | 7.6% |
| Operating Margin | 5.5% |
| Net Margin | 1.7% |
Returns
2.5%ROE
1.3%ROA
3.4%ROIC
Balance Sheet Health
Debt / Equity0.26x
Current Ratio1.92x
Net Debt$28.3M
Cash & Equivalents$213.2M
Quality Metrics
Altman Z-Score3.12
Piotroski F-Score6 / 9
FCF Margin2.6%
Rule of 405.7
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $1.5B
Diluted EPS$0.86TTMFY2025: $0.59
Dividend
No dividend
Capital Allocation
R&D Spend$96M
Capex Intensity2.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Automotive | $1.4B | +1.9% | View detailsExpected to benefit from the transformational combination with Modine Performance Technologies, on track to close by the end of 2026. |
| Medical | $49.8M | -0.1% | View detailsFocused on scaling core technologies across adjacent markets. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.